Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
CardieX Limited ( (AU:CDX) ) has provided an announcement.
Cardiex Limited has launched its CONNEQT Pulse, an advanced personal arterial health monitor, alongside the CONNEQT App in the United States. Initial deliveries of 3,000 Pulse units have begun, with additional units en route, while the app is available for download on iOS and Android platforms. The app offers features like a digital health coach, comprehensive arterial health metrics, and the ability to share data with healthcare professionals, aiming to enhance user engagement in cardiovascular health management. This dual launch marks a significant step in Cardiex’s strategy to penetrate the U.S. market, with early positive feedback from customers and the healthcare sector indicating strong potential for market impact.
More about CardieX Limited
Cardiex Limited is a company focused on advancing longevity through medical technology in vascular health, offering a range of medical and home health devices and digital solutions. Their products target hypertension, cardiovascular disease, and other vascular health disorders, leveraging the company’s leading SphygmoCor® vascular biomarker technology. Cardiex is listed on the Australian Stock Exchange as ASX:CDX.
YTD Price Performance: 0%
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $26.64M
Learn more about CDX stock on TipRanks’ Stock Analysis page.
